Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

BridgeBio Pharma - 53 Year Dividend History | BBIO

Historical dividend payout and yield for BridgeBio Pharma (BBIO) since 1972. The current TTM dividend payout for BridgeBio Pharma (BBIO) as of June 10, 2025 is $0.00. The current dividend yield for BridgeBio Pharma as of June 10, 2025 is 0.00%.
  
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $7.411B $0.222B
BridgeBio Pharma Inc. discovers, develops and innovates drugs for genetic diseases. The Company's product platform consists of Mendelian, Oncology and Gene therapy. Its product pipeline includes BBP-265, BBP-831, BBP-631 and BBP-454 which are in clinical stage. BridgeBio Pharma Inc. is based in CA, United States.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $20.726B 7.41
Dr Reddy's Laboratories (RDY) India $13.047B 23.68
Supernus Pharmaceuticals (SUPN) United States $1.863B 15.12
Bausch Health Cos (BHC) Canada $1.799B 1.30
Amphastar Pharmaceuticals (AMPH) United States $1.255B 8.42
Taysha Gene Therapies (TSHA) United States $0.601B 0.00
Personalis (PSNL) United States $0.477B 0.00
Assembly Biosciences (ASMB) United States $0.123B 0.00
Sol-Gel Technologies (SLGL) Israel $0.020B 0.00
Evoke Pharma (EVOK) United States $0.005B 0.00
Teligent (TLGT) United States $0.000B 0.00